ConductScience.org, home

Paper26322900

Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.

Guo F and 4 others. ACS Appl Mater Interfaces, 2015. Cited by 81 papers, by iCite.

Cite this record

ConductScience Library. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes. Papers, record 26322900. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26322900

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
PubMed
Journal
ACS Appl Mater Interfaces
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
81
iCite
Relative citation ratio, by iCite
3
iCite
Revised in PubMed
2022-03-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guo FFang
2Yu MMeng
3Wang JJinping
4Tan FFengping
5Li NNan

Source PubMed

Download CSV of authors

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug CarriersMajor topic
Folic AcidMajor topic
Hyperthermia, InducedMajor topic
IndolesMajor topic
NanoparticlesMajor topic
NeoplasmsMajor topic
Theranostic NanomedicineMajor topic
TitaniumMajor topic
Animals
Binding, Competitive
Cell Death
Cell Line, Tumor
Doxorubicin
Drug Delivery Systems
Female
Humans
Liposomes
Mice, Inbred BALB C
Mice, Nude
Microbubbles
Particle Size
Phototherapy
Surface Properties
Temperature
Tissue Distribution
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.

PMIDTitleJournalYearIn PapersSource
41717824Ejecta-Modulated Bubble Dynamics Play a Dominant Role in Stone Retropulsion.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41717824PubMed
41129032Bioorthogonal liposome-based sequential drug delivery system for enhanced tumor accumulation and targeted therapy.Drug Deliv Transl Res2026https://conductscience.org/library/papers/41129032PubMed
39725974Spatiotemporal-controllable ROS-responsive camptothecin nano-bomb for chemo/photo/immunotherapy in triple-negative breast cancer.J Nanobiotechnology2024https://conductscience.org/library/papers/39725974PubMed
39309187EGFR-Targeted and NIR-Triggered Lipid-Polymer Hybrid Nanoparticles for Chemo-Photothermal Colorectal Tumor Therapy.Int J Nanomedicine2024https://conductscience.org/library/papers/39309187PubMed
38454419The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.J Nanobiotechnology2024https://conductscience.org/library/papers/38454419PubMed
38407670Theranostics: a multifaceted approach utilizing nano-biomaterials.Discov Nano2024https://conductscience.org/library/papers/38407670PubMed
38276487Targeted PLGA-Chitosan Nanoparticles for NIR-Triggered Phototherapy and Imaging of HER2-Positive Tumors.Pharmaceutics2023https://conductscience.org/library/papers/38276487PubMed
36839765Photothermal Properties of IR-780-Based Nanoparticles Depend on Nanocarrier Design: A Comparative Study on Synthetic Liposomes and Cell Membrane and Hybrid Biomimetic Vesicles.Pharmaceutics2023https://conductscience.org/library/papers/36839765PubMed
35697894Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation.Drug Deliv Transl Res2023https://conductscience.org/library/papers/35697894PubMed
35659113NIR-Mediated drug release and tumor theranostics using melanin-loaded liposomes.Biomater Res2022https://conductscience.org/library/papers/35659113PubMed
35548210Mitochondria targeting IR780-based nanoGUMBOS for enhanced selective toxicity towards cancer cells.RSC Adv2018https://conductscience.org/library/papers/35548210PubMed
35541810Magnetically targeted nanoparticles for imaging-guided photothermal therapy of cancer.RSC Adv2019https://conductscience.org/library/papers/35541810PubMed
35540567Near-infrared-induced IR780-loaded PLGA nanoparticles for photothermal therapy to treat breast cancer metastasis in bones.RSC Adv2019https://conductscience.org/library/papers/35540567PubMed
35335518Nanocluster-Based Drug Delivery and Theranostic Systems: Towards Cancer Therapy.Polymers (Basel)2022https://conductscience.org/library/papers/35335518PubMed
34550040Topically applied liposome-in-hydrogels for systematically targeted tumor photothermal therapy.Drug Deliv2021https://conductscience.org/library/papers/34550040PubMed
32642819Dual-pH Sensitive Charge-Reversal Drug Delivery System for Highly Precise and Penetrative Chemotherapy.Pharm Res2020https://conductscience.org/library/papers/32642819PubMed
32104466Current developments in drug delivery with thermosensitive liposomes.Asian J Pharm Sci2019https://conductscience.org/library/papers/32104466PubMed
31635367Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery.Pharmaceutics2019https://conductscience.org/library/papers/31635367PubMed
31360117Molecular Mechanism for Selective Cytotoxicity towards Cancer Cells of Diselenide-Containing Paclitaxel Nanoparticles.Int J Biol Sci2019https://conductscience.org/library/papers/31360117PubMed
31118609IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer.Int J Nanomedicine2019https://conductscience.org/library/papers/31118609PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26322900

GET https://conductscience.org/api/papers/v1/26322900/cited_by?page=2